Health
Azithromycin use for treating COVID-19 may increase risk of cardiac events – News-Medical.net
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest.
Reviewed by Emily Henderson, B.Sc.Sep 16 2020
Debates over whether hydroxychloroquine should be taken to help lessen the duration and impact of COVID-19 have revolved around the drug’s reputation for causing cardiac events such as abnormal heart rhythms or beats and cardiac arrest. Because of this, the U.S. Food and Drug Administration has revoked emergency use authorization for the drug in treating COVID-19.
Another drug, azithromycin — a commonly-prescribed antibiotic — also is being inves…
-
General18 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General17 hours agoAustralian share market set to dive as threat of US recession grows